Vitrakvi User Reviews & Ratings
Vitrakvi has an average rating of 9.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Solid Tumors | 1 reviews for Solid Tumors | 14 medications |
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about Vitrakvi (larotrectinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
For Solid Tumors "I've only been taking Vitrakvi a couple of months for squamous cell cancer in the left head and neck after already having chemo and radiation. With no fresh scans, I can't say anything about effectiveness, but I'm not expecting much of a turnaround, if at all, mainly because of a negative prognosis. But I can say I haven't had any bad side effects, but I didn't with chemo either-lucky, I guess. No nausea or anything like that, so I would say don't concern yourself over that. Good luck. Thank you, Bayer, very much for the opportunity."